Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 3.18B | $ 3.36B | $ 3.66B | $ 3.48B | $ 3.59B |
Total Assets | $ 5.67B | $ 5.81B | $ 5.81B | $ 5.44B | $ 5.40B |
Total Debt | $ 1.81B | $ 1.95B | $ 2.02B | $ 1.64B | $ 1.84B |
Net Debt | $ -1.37B | $ -1.40B | $ -1.64B | $ -1.84B | $ -1.75B |
Total Liabilities | $ 2.36B | $ 2.51B | $ 2.53B | $ 2.20B | $ 2.46B |
Stockholders Equity | $ 3.31B | $ 3.30B | $ 3.28B | $ 3.24B | $ 2.94B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |